P3 Health Partners Inc.
General ticker "PIII" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $19.8M (TTM average)
P3 Health Partners Inc. does not follow the US Stock Market performance with the rate: -6.9%.
Estimated limits based on current volatility of 12.0%: low 10.76$, high 13.68$
Factors to consider:
- Total employees count: 400 as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market competition, Dependence on government healthcare programs, Limited operating history, Cybersecurity threats, Regulatory and compliance
- Current price 41.8% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.08$, 7.09$]
- 2026-12-31 to 2027-12-31 estimated range: [1.48$, 5.07$]
Financial Metrics affecting the PIII estimates:
- Positive: with PPE of -0.1 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 1.03 > -0.60
- Positive: -9.55 < Industry operating profit margin (median), % of 0.04
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of 5.14 <= 5.46
- Positive: Shareholder equity ratio, % of -23.64 <= 19.24
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term PIII quotes
Long-term PIII plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,266.38MM | $1,500.45MM | $1,459.08MM |
| Operating Expenses | $1,434.31MM | $1,821.11MM | $1,729.38MM |
| Operating Income | $-167.93MM | $-320.66MM | $-270.30MM |
| Non-Operating Income | $-15.80MM | $14.67MM | $-50.76MM |
| Interest Expense | $15.98MM | $22.17MM | $55.03MM |
| Income(Loss) | $-183.73MM | $-305.99MM | $-321.06MM |
| Taxes | $2.69MM | $4.39MM | $-2.02MM |
| Net Income(Loss)* | $-57.77MM | $-135.85MM | $-147.95MM |
| Stockholders Equity | $142.13MM | $75.94MM | $-155.23MM |
| Assets | $860.97MM | $783.42MM | $656.64MM |
| Operating Cash Flow | $-76.03MM | $-110.13MM | $-91.24MM |
| Capital expenditure | $1.83MM | $0.00MM | $0.08MM |
| Investing Cash Flow | $-1.83MM | $14.53MM | $0.13MM |
| Financing Cash Flow | $100.33MM | $98.77MM | $72.81MM |
| Earnings Per Share** | $-30.44 | $-46.78 | $-45.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.